To evaluate their therapeutic potential, we focused on SMA and created a transgenic mouse line with germline-integrated SM25, an ExSpeU1 that efficiently promotes SMN2 exon 7 inclusion39, 40. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.